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 2 
Abstract 26 
In adipose tissue, D-dopachrome tautomerase (DDT), a cytokine with structural similarity to 27 
macrophage migration inhibitory factor, is mainly expressed in adipocytes rather than 28 
preadipocytes and acts as an anti-obesity adipokine in an autocrine manner.  However, its 29 
transcriptional regulation is largely unknown.  In order to explore molecules affecting DDT 30 
transcription, a chemical library screening using HEK293 cells stably expressing a DDT 31 
promoter-reporter construct was performed.  Several derivatives of 32 
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), an AMP-activated protein 33 
kinase (AMPK) activator, were identified as transcriptional activators of the DDT gene.  34 
Furthermore, DDT mRNA levels were reduced in SGBS adipocytes treated with compound C, 35 
an AMPK inhibitor, suggesting involvement of AMPK in DDT transcription.  Overexpression 36 
of the FOXO1 constitutive active form reduced transcriptional activity of the DDT gene in 37 
SGBS cells, but increased it in HEK293 cells.  Cell-type specific effects were also observed in 38 
the DDT gene expression of cells treated with AS1842856, a FOXO1 inhibitor.  Finally, 39 
involvement of the mammalian target of rapamycin (mTOR) signaling in DDT transcription in 40 
SGBS adipocytes was investigated.  Rapamycin, an inhibitor of mTOR, increased DDT mRNA 41 
levels and attenuated the inhibitory effects of compound C on DDT mRNA levels in SGBS 42 
adipocytes.  In conclusion, DDT transcription may be regulated in a cell-dependent manner, 43 
and were enhanced by AMPK activation in SGBS adipocytes through inhibiting the mTOR 44 
signaling. 45 
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1. Introduction 58 
 59 
   Adipose tissue is not only an organ contributing to energy homeostasis by storage and 60 
supply of energetic molecules, but is also an endocrine organ secreting biologically active 61 
proteins termed “adipokines” [1].  Adipokines have important roles in health maintenance by 62 
regulating diverse processes including appetite and satiety, fat distribution, inflammation, blood 63 
pressure, hemostasis, and endothelial function [2].  In the previous study, D-dopachrome 64 
tautomerase (DDT) was found as an adipokine that improved insulin resistance caused by 65 
obesity and regulated lipid metabolism in adipocytes [3]. 66 
   DDT has been originally identified as an enzyme that converts D-dopachrome into 67 
5,6-dihydroxyindole, but its physiological significance is unknown [4].  Recently, DDT has 68 
come to be regarded as a family member of macrophage migration inhibitory factor (MIF), a 69 
cytokine involved in the amplification of inflammatory and immune responses, due to 70 
similarities in structure and function [5-8].  DDT acts co-operatively with MIF through CD74, 71 
a MIF receptor, to activate the proinflammatory pathway [8] and to promote tumor growth [7, 9, 72 
10].  However, DDT has been reported to have distinct functions from MIF in adipose tissue.  73 
MIF knockout mice exhibit improvement of insulin sensitivity in adipose tissue by an increase 74 
of the glucose uptake [11] and reduction of the macrophage infiltration [12], suggesting the 75 
unfavorable function of MIF in adipose tissue.  On the other hand, administration of 76 
recombinant DDT ameliorates the glucose intolerance of obese mice [3] and inhibits 77 
adipogenesis in SGBS cells, a human preadipocyte cell line [13].  More recently, DDT was 78 
demonstrated to accelerate wound healing in adipose tissue in the presence of neutralizing 79 
anti-MIF antibody and the ability of DDT to recruit macrophages into the inflamed adipose 80 
tissue was lower than that of MIF [14].  These suggest that DDT has more beneficial roles than 81 
MIF in adipose tissue.  82 
   Differences in gene expression between DDT and MIF in adipose tissue have been reported.  83 
MIF is expressed in both adipocytes and preadipocytes, and its mRNA levels were not elevated 84 
during adipogenesis [15].  MIF mRNA levels in subcutaneous abdominal adipocytes are 85 
positively associated with adipocyte size and insulin resistance [16].  On the other hand, DDT 86 
mRNA levels are increased in an adipocyte differentiation-dependent manner and the mRNA 87 
levels in human adipocytes are negatively correlated with obesity-related clinical parameters 88 
such as body mass index, and visceral and subcutaneous fat areas [3].  Thus, transcriptional 89 
regulation of the DDT gene may be different from that of MIF in adipose tissue; however, the 90 
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underlying transcriptional mechanism is largely unexplored. 91 
   In order to uncover the molecular mechanisms of transcriptional regulation of the DDT gene 92 
in adipocytes, we first explored the molecules that influence transcription from a chemical 93 
library using HEK293 cells stably expressing a DDT promoter-reporter construct, and then 94 
validated the effects using SGBS cells and the differentiated adipocytes (SGBS adipocytes).  95 
Consequently, we found that 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) 96 
and its derivatives enhance DDT transcription; therefore, we examined the signaling pathway.  97 
 5 
2. Materials and Methods 98 
 99 
2.1. Materials 100 
   AICAR, compound C, three kinds of siRNAs against human SIRT1 (Mission siRNA: 101 
Hs_SIRT1_3666, 3669, 3671) and the control siRNAs, and mouse anti-β-actin antibody were 102 
purchased from Sigma (St Louis, MO, USA).  AS1842856 was purchased from Millipore 103 
(Billerica, MA, USA).  Rapamycin was purchased from Tokyo Chemical Industry (Tokyo, 104 
Japan).  Rabbit antibodies against AMP-activated protein kinase (AMPK)-α, phosphorylated 105 
AMPKα (Thr-172), S6 kinase (S6K), and phosphorylated S6K were purchased from Cell 106 
signaling (Danvers, MA, USA).  Rabbit anti-forkhead transcription factor O1 (FOXO1) 107 
antibody was purchased from Abcam (Cambridge, UK).  Rabbit anti-acetylated FOXO1 108 
(Ac-FKHR (D-19)) antibody was purchased from SantaCruz Biotechnologies (Santa Cruz, CA, 109 
USA). 110 
 111 
2.2. A Chemical library 112 
   A chemical library, including natural products and their synthetic intermediates, heterocyclic 113 
compounds, peptides, and nucleosides (1,599 compounds) from the Graduate School of 114 
Pharmaceutical Science, Tokushima University was prepared as an approximately 10 mM stock 115 
solution in dimethyl sulfoxide (DMSO).  116 
 117 
2.3. Cell culture 118 
   SGBS cells were maintained and made to differentiate into adipocytes as described by 119 
Wabitsch et al. [17].  The differentiated adipocytes were used in experiments on day 7 after 120 
adipogenic induction.  HEK293 cells were cultured with Dulbecco's modified eagle medium 121 
containing 10% fetal bovine serum.  These cells were treated with each chemical compound 122 
for 24 h or indicated time, and then used for quantitative real-time reverse transcription PCR 123 
(qRT-PCR) and western blotting.  Cells treated with equal amounts of DMSO were used as 124 
controls.  Transfection to SGBS cells and HEK293 cells was performed using the Neon 125 
Transfection System (Thermo Fisher Scientific, Waltham, MA, USA) and Effectene 126 
Transfection Reagent (Qiagen, Valencia, CA, USA), respectively. 127 
 128 
2.4. Construction of reporter and expression vectors 129 
   A putative promoter region (-2,903/+135 from the transcription start site of the DDT gene) 130 
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and the deletion mutants were amplified from genomic DNA extracted from HEK293 cells.  131 
PCR products were inserted into the pGL4.17 luciferase vector (Promega, Madison, WI, USA) 132 
or pGL4.17 without the putative FOXO1 binding motifs (nucleotides at position from 5,526 to 133 
5,547 in pGL4.17), which was made using site-directed mutagenesis.  Then, construction of 134 
each mutated luciferase reporter plasmid with lacking putative FOXO1 binding motif(s) (-1543 135 
to -1536 and/or -172 to -166) in the DDT promoter was carried out by standard PCR-based 136 
site-directed mutagenesis.  The cDNA encoding human FOXO1 was amplified from total RNA 137 
extracted from SGBS cells by RT-PCR using each specific primer set and was inserted into the 138 
expression vector, pcDNA3.1+.  An expression plasmid for a constitutive active form of 139 
FOXO1 (FOXO1(CA)), a triple alanine mutant of FOXO1 at T24, S256, and S319 sites, was 140 
made using site-directed mutagenesis.  141 
 142 
2.5. Luciferase assay 143 
   Firefly and Renilla luciferase activities were measured using the Dual Luciferase® Reporter 144 
Assay System (Promega) on the TriStar LB 941 Multi-label plate reader (Berthold Technologies, 145 
Pforzheim, Germany) 24 h after co-transfection of reporter vectors and Renilla luciferase vector 146 
(pGL4.74; Promega).  The firefly luciferase activity was normalized by the Renilla luciferase 147 
activity. 148 
 149 
2.6. Screening from the chemical library 150 
   HEK293 cells stably expressing the DDT promoter (-2,903/+135) reporter vector were 151 
selected in medium containing G418 (Sigma) for 2 weeks after transfection.  The cells were 152 
seeded at 10,000 cells/well in white 96-well plates and incubated for 2 days.  Then, the cells 153 
were treated with each 10 µM compound from the chemical library or equal amount of DMSO 154 
for 24 h and the luciferase activity was measured using a Luciferase Assay System (Promega).  155 
The activity was normalized with that of cells stably expressing the control reporter plasmid, 156 
pGL4.24 (Promega), which were treated in the same way. 157 
 158 
2.7. qRT-PCR 159 
   Total RNA from the cells was extracted with ISOGEN (Nippongene, Toyama, Japan).  160 
Each cDNA was synthesized from total RNA using the PrimescriptTM RT Reagent Kit (Takara, 161 
Shiga, Japan).  qRT-PCR was performed on an Applied Biosystems Prism 7300 Real Time 162 
PCR system (Applied Biosystems, Foster City, CA, USA) using THUNDERBIRDTMSYBR® 163 
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qPCR Mix (Toyobo, Osaka, Japan).  The expression of each gene was normalized to that of the 164 
genes encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or TATA binding protein 165 
(TBP).  The following pairs of primers were used: DDT forward: 5'-CTT GGA GTC CTG 166 
GCA GAT TG-3', reverse: 5'-AAT GTT GCA TGC GGG ATA AT-3'; GAPDH forward: 167 
5'-GAA GGT GAA GGT CGG AGT C-3', reverse: 5'-GAA GAT GGT GAT GGG ATT TC-3'; 168 
TBP forward: 5'-CAGCGTGACTGTGAGTTGCT-3', reverse: 5'-TGG TTC ATG GGG AAA 169 
AAC AT-3'. 170 
 171 
2.8. Chromatin immunoprecipitation (ChIP) assay 172 
   SGBS cells overexpressing FOXO1(CA) were fixed with 1% formaldehyde for 10 min and 173 
the cross-linking was stopped by addition of 0.15 M glycine.  Then, the cells were lysed in 174 
SDS buffer (50 mM Tris, pH 8.0, 10 mM EDTA, 1% sodium dodecyl sulfate (SDS)) and 175 
sonicated to yield chromatin fragments of approximately 500 bp in length with the 176 
Bioruptor-UCW310 (Diagenode, Liége, Belgium).  The lysates were incubated with 177 
anti-FOXO1 antibody or normal rabbit IgG for 24 h, followed by incubation with Protein 178 
G-sepharose 4 Fast Flow (GE Healthcare, Buckinghamshire, UK) for 2 h.  The beads were 179 
extensively washed and subjected to heat denaturation and digestion by proteinase K.  DNA 180 
was further purified by phenol/chloroform extraction and ethanol precipitation.  PCR was 181 
performed with Ex Taq Polymerase (Takara) using each primer set.  As a positive control for 182 
ChIP using anti-FOXO1 antibody, FOXO1 binding region of the decidual protein induced by 183 
progesterone (DEPP) gene was amplified [18].  Normal human genomic DNA (Promega) was 184 
used as a positive control for PCR amplification.  The following pairs of primers were used: 185 
F1 forward: 5'-GAG ACA GGG TGG GTC CAC TA-3', reverse: 5'-ACA GCA ACC TGG CTT 186 
CTC AT-3'; F2 forward: 5'-CTC TCC CAT GCC TCC TCA TA-3', reverse: 5'-CAC TGA AAG 187 
GCC GAC AGA GT-3'; NC1 forward: 5'-GTA GAG ACG GGG TTT CGT CA-3', reverse: 188 
5'-TGC CTG TGT AGC CTC TTG TG-3'; NC2 forward: 5'-AGC TCT GAC TTT CCG TGC 189 
TC-3', reverse: 5'-TGA AAA GTT TTG CCC GAA GT-3'; PC1 forward: 5'-CCT GTG CTG 190 
CTG ATT TTT CA-3', reverse: 5'-TCG GAA GGC TGT CTT AGG AA-3'. 191 
 192 
2.9. Western blotting  193 
   The cell lysates were subjected to SDS-polyacrylamide gel electrophoresis and blotted to 194 
PVDF membranes (Immobilon Transfer Membranes; Millipore).  After incubation in blocking 195 
solution (Blocking One; Nakalai tesque, Kyoto, Japan), the membranes were incubated with 196 
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each primary antibody.  Then, the membranes were incubated with an anti-rabbit or -mouse 197 
IgG-horseradish peroxidase-conjugated secondary antibody (GE Healthcare).  Signal was 198 
detected using Immobilon Western Detection Reagent (Millipore) and exposed to X-ray film. 199 
 200 
2.10. Statistical analysis 201 
   Each experiment was repeated at least three times.  Data were expressed as the mean ± 202 
SEM.  Statistical analyses were performed using a Student’s t-test.  Differences were 203 
considered to be significant when the P-value was less than 0.05.  204 
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3. Results 205 
 206 
3.1. Identification of proximal promoter region of the human DDT gene 207 
   To identify the promoter region of the human DDT gene, we first constructed a reporter 208 
plasmid that has a fragment containing the sequence between -2,903 and +135 bp relative to the 209 
transcription start site of the DDT gene upstream of the firefly luciferase gene, and assessed the 210 
luciferase activity of SGBS cells transfected with the reporter plasmid during adipogenic 211 
differentiation.  The promoter activity was approximately 190-fold higher than cells 212 
transfected with the empty reporter plasmid even if under basal conditions without adipogenic 213 
induction (day 0), and the activity was further increased in a differentiation-dependent manner 214 
(Fig. 1A) in accordance with the mRNA expression pattern as previously reported [3].  To 215 
narrow the promoter region, a series of deletion mutants of the promoter was investigated using 216 
SGBS cells.  Consequently, the reporter construct containing regions from -200 to +23 of the 217 
DDT promoter exhibited the highest activity among the constructs (Fig. 1B).  DNA sequences 218 
in this region lacked a TATA box but contained two CAAT boxes and one GC box (Fig. 1C). 219 
 220 
3.2. AICAR and its derivatives enhanced DDT transcription in HEK293 and SGBS cells 221 
   In order to find a clue for the molecular mechanisms of DDT transcription, we attempted to 222 
explore the molecules that affect transcriptional activity of the DDT gene from a chemical 223 
library.  We used HEK293 cells that stably express the DDT promoter (-2,903/+135)-reporter 224 
for high-throughput screening because SGBS cells were not suitable for establishment of stable 225 
clones due to difficulty in maintaining a long-term culture after transfection.  DDT mRNA 226 
levels in HEK293 cells were comparable to those in SGBS cells (data not shown).  We 227 
obtained 28 compounds (10 activators and 18 inhibitors) with more than a 2-fold change in the 228 
luciferase activity compared with the DMSO treatment as a control.  Of note, 7 of the 10 229 
activator candidates had similar structures with AICAR, a selective activator of AMPK (Figs. 230 
2A and B).  Next, whether AICAR and the 3 derivatives of SY142, SY145, and SY148 [19], 231 
whose luciferase activities were relatively high, affect DDT mRNA levels in both SGBS cells 232 
and SGBS adipocytes was investigated.  AICAR and SY148 increased DDT mRNA levels in 233 
both SGBS cells and the differentiated adipocytes (Figs. 2C and D).  SY148 as well as AICAR 234 
were confirmed to have the potential to activate AMPK in SGBS adipocytes (Fig. 2E).  235 
Furthermore, compound C, an AMPK inhibitor, decreased DDT mRNA levels in SGBS 236 
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adipocytes (Fig. 2F).  These results suggested that AMPK activation enhanced DDT gene 237 
expression in SGBS adipocytes. 238 
 239 
3.3. FOXO1 binds to the promoter region of the DDT gene.  240 
   Next, we sought transcriptional regulation factors downstream of AMPK signaling and 241 
therefore focused on FOXO1, a transcription factor known to be activated through 242 
AMPK/SIRT1 pathway [20], because there are two putative FOXO1 binding consensus 243 
sequences (AAACAA/TTGTTT) in the DDT promoter region (Fig. 3A).  A ChIP assay 244 
revealed that FOXO1 bound to these two sites (Fig. 3B).  Next, the effects of FOXO1(CA) 245 
overexpression on transcriptional activity of the DDT gene in SGBS cells were investigated.  246 
As FOXO1(CA) markedly induced luciferase activity in control cells with an empty reporter 247 
plasmid, presumably due to the putative FOXO1 binding sequences in the vicinity of the 248 
multiple cloning site in the plasmid, we reconstructed the DDT promoter (-2,903/+135)-reporter 249 
and control empty plasmids lacking the sequences, and confirmed that influence of 250 
FOXO1(CA) on the basal luciferase activity of the newly constructed plasmids was negligible 251 
(supplementary Fig. 1).  Unexpectedly, FOXO1(CA) significantly inhibited transcriptional 252 
activity of the DDT gene and tended to decrease DDT mRNA levels in SGBS cells (Figs. 3C 253 
and D) and treatment of AS1842856, a FOXO1 inhibitor, in SGBS adipocytes increased DDT 254 
mRNA levels (Fig. 3E).  Furthermore, AICAR-induced deacetylation of FOXO1 in SGBS 255 
adipocytes (Fig. 3F) and increased DDT mRNA levels in SIRT1-knockdown SGBS cells were 256 
observed (Fig. 3G).  Thus, AMPK/SIRT1/FOXO1 pathway seems to rather inhibit the DDT 257 
gene expression in the SGBS adipocytes. 258 
   In contradiction to SGBS cells, overexpression of FOXO1(CA) in HEK293 cells 259 
demonstrated enhancement both of transcriptional activity and the mRNA levels of the DDT 260 
gene and AS1842856 also had opposite effects on DDT mRNA levels (supplementary Fig. 2).  261 
These results suggested that FOXO1 regulated DDT transcription in a cell-type specific manner.   262 
   Next, we performed luciferase assay using reporter constructs containing the mutated DDT 263 
promoter that lacks either or both of two putative FOXO1 binding sites (Fig. 3H).  Inhibition 264 
of luciferase activity by FOXO1(CA) overexpression was attenuated in SGBS cells transfected 265 
with reporter plasmids lacking FOXO1 binding site-2 (Fig. 3I), indicating that the binding site-2 266 
is involved in FOXO1-inhibited transcription of the DDT gene in SGBS cells.  267 
 268 
3.4. Inhibition of mTOR signaling enhanced DDT mRNA expression 269 
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   Finally, we investigated involvement of the mammalian target of rapamycin (mTOR) 270 
signaling in transcriptional regulation of the DDT gene.  AICAR and compound C decreased 271 
and increased phosphorylated levels of S6K, a target of mTOR, in SGBS adipocytes (Fig. 4A), 272 
respectively, suggesting AMPK/mTOR pathway in adipocytes.  Rapamycin, an inhibitor of 273 
mTOR, increased DDT mRNA levels (Fig. 4B) and abolished the inhibitory effects of 274 
compound C on DDT mRNA levels in SGBS adipocytes (Fig. 4C), suggesting that 275 
AMPK/mTOR signaling was one of the key pathways of DDT transcription in adipocytes.  276 
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4. Discussion 277 
 278 
   In this study, we found that AICAR and its derivatives induced transcription of the DDT 279 
gene in SGBS adipocytes by screening a chemical library.  AICAR is transformed into the 280 
corresponding 5'-monophosphate in cells and activates AMPK in several cell-types including 281 
adipocytes [21-25].  AMPK, a serine/threonine kinase protein complex, plays a central role to 282 
regulate cellular energy homeostasis.  Activation of AMPK in response to different cellular 283 
stresses that cause cellular ATP depletion, such as low glucose, hypoxia, ischemia, and heat 284 
shock, positively regulates signaling pathways for energy production and negatively regulates 285 
ATP-consuming biosynthetic processes [26].  AMPK phosphorylates a number of enzymes 286 
involved in these processes and transcription factors, including co-activators and co-repressors, 287 
to control the transcription [27].  In adipose tissue, activated AMPK inhibits both lipogenesis 288 
and lipolysis [21], resulting in restriction of efflux of fatty acids, molecules that induce insulin 289 
resistance.  Furthermore, AMPK has been reported to regulate the expression and secretion of 290 
adipokines in adipocytes.  In human adipose tissue, AICAR stimulates the expression of 291 
adiponectin that enhances insulin sensitivity and inhibits secretion of inflammatory cytokines 292 
including TNF-α, IL-6, and MIP-1α/β [24, 28].  Given that DDT is an adipokine that improves 293 
insulin resistance in obesity [3], our data suggest that activation of AMPK in adipose tissue may 294 
be beneficial in insulin-resistant states.  On the other hand, metformin, another AMPK 295 
activator, has been reported to reduce adiponectin expression in adipocytes differentiated from 296 
3T3-L1 cells, a mouse preadipocyte cell line [29].  Of note, we could not observe any 297 
significant effects of AICAR or compound C on mouse Ddt mRNA levels in 3T3-L1 cells (data 298 
not shown).  To uncover whether the involvement of AMPK in transcriptional regulation of 299 
the DDT gene is species-specific, further investigations are necessary. 300 
   We found that transcriptional activity of the DDT gene increased at the late stage of 301 
adipogenesis in SGBS cells.  Although AMPK activation has been reported to inhibit 302 
preadipocyte differentiation [30], the activity and physiological role of AMPK during adipocyte 303 
differentiation is not clear.  Based on reports that adiponectin and leptin secreted from 304 
differentiated adipocytes activate adipocyte AMPK in an autocrine manner [31, 32], AMPK 305 
activity should be increased in the late stage of adipogenesis as secretion of these adipokines 306 
increases.  Indeed, Thr172-phosphorylated levels of AMPK are reported to be increased in a 307 
differentiation-dependent manner in 3T3-L1 cells [33].  Thus, increase of transcriptional 308 
activity of the DDT gene at the late stage of adipogenesis in SGBS cells may depend on AMPK 309 
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activation.  Furthermore, DDT can activate AMPK in SGBS cells [3], suggesting that AMPK 310 
activation and DDT expression may form a positive loop to promote transcriptional activity of 311 
the DDT gene. 312 
   AMPK enhances SIRT1 activity by increasing cellular NAD+ levels, resulting in activation 313 
of FOXO1 [20].  Among all FOXO members, FOXO1 is highly expressed in 314 
insulin-responsive tissues including the pancreas, liver, skeletal muscle, and adipose tissue, and 315 
regulates gene transcription involved in glucose metabolism [34].  In the present study, 316 
FOXO1 exhibited opposite effects on transcriptional activity and mRNA levels of the DDT 317 
gene between SGBS cells and HEK293 cells, suggesting cell-type specific transcriptional 318 
regulation.  FOXO associates with a variety of unrelated transcription factors to regulate 319 
activation or repression of the target genes, and the complement of transcription factors is 320 
critical in determining the functions of FOXO in each tissue [35].  For example, 321 
CCAAT/enhancer binding protein α acts as a co-activator of FOXO1 to up-regulate mouse 322 
adiponectin gene expression in 3T3L1 cells [36].  Identification of the co-factors of FOXO1 323 
involved in DDT transcription in human adipocytes requires further consideration. 324 
   DDT mRNA levels down-regulated by the SIRT1/FOXO1 signaling pathway in SGBS cells 325 
implied another pathway downstream of AMPK in the DDT transcription and as a result, we 326 
found involvement of mTOR signaling (Fig. 4D).  AMPK suppresses mTOR complex 1 which 327 
controls the cellular metabolism in response to growth factors, hormones, nutrients, and energy 328 
levels, and stress signals [37].  Synthesis or secretion of adipokines appears to be under the 329 
control of mTOR signaling, but how mTOR signaling controls the expression and secretion of 330 
adipokines remains unknown [38]. 331 
   Throughout this study, alterations in DDT mRNA levels in SGBS cells or SGBS adipocytes 332 
were modest, even if statistically significant, compared with those in the transcriptional activity.  333 
This suggests that regions except for the promoter used in this study also participated in 334 
transcriptional regulation of the DDT gene and the regions may alleviate the positive effects on 335 
the mRNA expression.  Indeed, HIF1α and HIF2α have been reported to bind to the 336 
neighborhood of +365 bp downstream of the transcription start site of the DDT gene [10]; 337 
however, the DNA sequences were not included in our experiment.  Thus, our approach could 338 
not cover the entire aspect of DDT transcriptional regulation; however, this study demonstrated 339 
at least a partial involvement of AMPK/mTOR signaling in its transcription in SGBS 340 
(pre)adipocytes. 341 
    In conclusion, the present study revealed that the activation of AMPK enhanced DDT 342 
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transcription in SGBS cells by inhibiting the mTOR pathway.  Our results provided a clue for 343 
further understanding of DDT transcriptional regulation and for developing pharmaceutical 344 
drugs targeting transcription of DDT that have anti-obesity properties. 345 
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Figure legends 506 
 507 
Figure 1 508 
Identification of the proximal promoter region of the human DDT gene.  (A) Time-course of 509 
luciferase activity during adipogenesis in SGBS cells.  SGBS cells transfected with a reporter 510 
construct containing the upstream region (-2,903/+135) of the human DDT gene were subjected 511 
to adipogenic induction and the luciferase activities were measured at indicated time points.   512 
Data are shown relative to those of cells transfected with the control reporter plasmid.  513 
*P<0.05 (n=4).  (B) Comparison of luciferase activity in SGBS cells transfected with reporter 514 
constructs containing different lengths of 5'-flanking regions of the DDT gene.  Upstream 515 
region of the DDT gene and the 5'-flanking regions used are shown in the left diagrams and the 516 
activities are shown in the right graph.  The activities were measured 24 h after transfection.  517 
Data are shown relative to the control reporter plasmid-transfected samples.  *P<0.05 (n=4).  518 
(C) Nucleotide sequence of proximal promoter region of the human DDT gene.  Sequence 519 
numbering is relative to the transcription start site. Putative GC box and CAAT boxes are 520 
underlined and boxed, respectively. 521 
 522 
Figure 2 523 
Involvement of AMPK in transcription and mRNA expression of the DDT gene.  (A) Chemical 524 
structures of AICAR (boxed) and its derivatives that were screened from a chemical library as 525 
transcriptional activators of DDT.  (B) Effects of derivatives of AICAR on luciferase activity 526 
in HEK293 cells stably expressing a DDT promoter (-2,903/+135)-reporter construct.  The 527 
cells were treated with each 10 µM derivative for 24 h.  The activity was normalized to that in 528 
HEK293 cells stably expressing a control reporter construct, which were treated with the same 529 
compounds.  Data are shown relative to DMSO treatment.  *P<0.05 (n=4).  (C, D) Effects 530 
of AICAR and 3 derivatives on DDT mRNA expression in SGBS cells (C) and SGBS 531 
adipocytes (D).  The cells were treated with 1 mM AICAR and each 10 µM derivative for 24 h, 532 
and then DDT mRNA levels were quantified by qRT-PCR.  Data are shown relative to DMSO 533 
treatment.  *P<0.05 (n=3).  (E) AMPK activation by AICAR and SY148 in SGBS adipocytes.  534 
SGBS adipocytes were treated with 1 mM AICAR and indicated concentration of SY148 for 24 535 
h.  As an internal control, β-actin levels are shown.  (F) Effects of compound C on DDT 536 
mRNA levels in SGBS adipocytes.  DDT mRNA levels were measured by qRT-PCR in SGBS 537 
adipocytes treated with 10 µM compound C (black column) or DMSO (white column) for 24 h.  538 
 21 
Data are shown relative to DMSO treatment.  *P<0.05 (n=3). 539 
 540 
Figure 3 541 
Involvement of FOXO1 on transcription and mRNA expression of the DDT gene.  (A) A 542 
diagram of the DDT promoter region and the position of each primer set used for the ChIP assay.  543 
Two putative FOXO1 binding sites (TTGTTT and AAACAA) were identified in the DDT 544 
promoter region.  F1 and F2 primer sets were designed to amplify regions including each motif.  545 
(B) Representative images of the ChIP assay in SGBS cells transiently overexpressing 546 
FOXO1(CA).  PCR using each primer set of F1 (178 bp), F2 (239 bp), and negative controls 547 
(NC1 (197 bp) and NC2 (214 bp)) was performed.  As a positive control for the ChIP assay, a 548 
primer set including the FOXO1 binding region of DEPP was used (PC1: 305 bp).  As a 549 
positive control for PCR, the FOXO1 binding region of DEPP amplified from normal human 550 
genomic DNA was applied to lane PC2. (C) Effects of overexpressed FOXO1(CA) on 551 
transcriptional activity of the DDT gene in SGBS cells.  The cells were co-transfected with the 552 
DDT promoter (-2,903/+135)-reporter construct and FOXO1(CA) expression vector or the 553 
empty vector and the luciferase activities were measured 24 h after transfection.  (D) Effects of 554 
FOXO1 (CA) overexpression on DDT mRNA levels in SGBS cells.  The cells were transfected 555 
with the FOXO1(CA) expression vector or the empty vector and DDT mRNA levels were 556 
measured by qRT-PCR 24 h after transfection.  (E) Effects of AS1842856, a FOXO1 inhibitor, 557 
on DDT mRNA expression in SGBS adipocytes.  DDT mRNA levels were measured by 558 
qRT-PCR in the cells treated with 1 µM AS1842856 or DMSO for 24 h. (F) Representative 559 
images of western blotting using anti-acetylated FOXO1 antibody (Ac-FOXO1), anti-FOXO1 560 
antibody, and β-actin in SGBS adipocytes treated with DMSO or 1 mM AICAR for 12 h.  (G) 561 
Effects of SIRT1 knockdown on DDT gene expression in SGBS cells.  SGBS cells were 562 
transfected with siRNA against SIRT1 (siSIRT1) or control siRNA (control), and DDT (right) 563 
and SIRT1 (left) mRNA levels were measured by qRT-PCR 24 h after transfection.  (H) 564 
Diagrams of wild type DDT promoter (WT) and each mutant that lacks either of FOXO1 565 
binding site-1 (M1) or FOXO binding site-2 (M2), or both (M1/2).  (I) Effect of overexpressed 566 
FOXO1(CA) on luciferase activity in SGBS cells transfected with each reporter construct.  #P 567 
< 0.05 vs. data of cells co-transfected with WT reporter construct and FOXO1(CA) (gray 568 
column) (n=3).  Data are shown relative to each control (white column).  *P < 0.05 vs. each 569 
control (white columns) (n=3).  570 
 571 
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Figure 4 572 
Involvement of the mTOR pathway in transcription and mRNA expression of the DDT gene in 573 
SGBS adipocytes.  (A) Inhibitory effects of AICAR on the mTOR pathway.  Phosphorylated 574 
S6K protein levels were assessed by Western blot analysis of SGBS adipocytes treated with 1 575 
mM AICAR, 1 µM compound C, or DMSO for 12 h.  Representative images are shown.  (B) 576 
Effects of rapamycin, an mTOR inhibitor, on DDT mRNA levels in SGBS adipocytes.  DDT 577 
mRNA levels were measured by qRT-PCR of SGBS adipocytes treated with 0.1 µM rapamycin 578 
(black column) or DMSO (white column) for 24 h.  Data are shown relative to DMSO 579 
treatment.  (C) Effects of rapamycin on DDT mRNA levels in SGBS adipocytes in the 580 
presence of compound C.  The levels were measured by qRT-PCR of SGBS adipocytes treated 581 
with 0.1 µM rapamycin (black column) or DMSO (gray column) with 10 µM compound C for 582 
24 h.  Data are shown relative to samples treated with DMSO only (white column).  *P<0.05 583 
(n=3).  (D) Schematic model of transcriptional regulation of the DDT gene in SGBS 584 
adipocytes. 585 
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Supplementary Figure 1. 
 
 
Luciferase activities of pGL4.17 in HEK293 (A) and SGBS cells (B) transfected with 
pcDNA3.1+ (open columns) or FOXO1(CA) (gray columns).  Luciferase activities of pGL4.17 
increased in response to FOXO1(CA) in both cell-types despite lack of promoter sequences.  
The pGL4.17 lacking sequences (at the position from 5,526 to 5,547), including the putative 
FOXO1 binding motifs (pGL4.17 ΔFBD), exhibited no FOXO1(CA) effects on the basal 
luciferase activity. 
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Supplementary Figure 2. 
 
 
Involvement of FOXO1 on transcription and mRNA levels of the DDT gene in HEK293 cells.  
(A) Effects of overexpressed FOXO1(CA) on transcriptional activity of the DDT gene in 
HEK293 cells.  The cells were co-transfected with the DDT promoter (-2,903/+135)-reporter 
construct and FOXO1(CA) expression vector or the empty vector and the luciferase activities 
were measured 24 h after transfection. (B) Effects of FOXO1 (CA) overexpression on DDT 
mRNA levels in HEK293 cells.  The cells were transfected with the FOXO1(CA) expression 
vector or the empty vector and DDT mRNA levels were measured by qRT-PCR 24 h after 
transfection.  (C) Effects of AS1842856, a FOXO1 inhibitor, on DDT mRNA expression in 
HEK293.  DDT mRNA levels were measured by qRT-PCR in the cells treated with 1 µM 
AS1842856 or DMSO for 24 h.  Data are shown relative to empty vector-transfected samples 
or DMSO treatment.  *P<0.05 (n=3). 
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